Emerging Role of Circulating Tumor DNA for Early Detection of Recurrence in Biliary Tract Cancers
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Azad T, Chaudhuri A, Fang P, Qiao Y, Esfahani M, Chabon J
. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer. Gastroenterology. 2019; 158(3):494-505.e6.
PMC: 7010551.
DOI: 10.1053/j.gastro.2019.10.039.
View
2.
Banales J, Marin J, Lamarca A, Rodrigues P, Khan S, Roberts L
. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020; 17(9):557-588.
PMC: 7447603.
DOI: 10.1038/s41575-020-0310-z.
View
3.
Reinert T, Vesterman Henriksen T, Christensen E, Sharma S, Salari R, Sethi H
. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer. JAMA Oncol. 2019; 5(8):1124-1131.
PMC: 6512280.
DOI: 10.1001/jamaoncol.2019.0528.
View
4.
Moris D, Palta M, Kim C, Allen P, Morse M, Lidsky M
. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2022; 73(2):198-222.
DOI: 10.3322/caac.21759.
View
5.
VanderWalde A, Spetzler D, Xiao N, Gatalica Z, Marshall J
. Microsatellite instability status determined by next-generation sequencing and compared with PD-L1 and tumor mutational burden in 11,348 patients. Cancer Med. 2018; 7(3):746-756.
PMC: 5852359.
DOI: 10.1002/cam4.1372.
View